Ludmila Prokunina-Olsson is Awarded the 2022 ICIS Mentorship Award

Ludmila (Mila) Prokunina-Olsson has been chosen for the 2022 ICIS Mentorship Award in recognition of her significant contributions to the field of immunity and cancer genetics through not only her own seminal discoveries and scientific accomplishments but also through the next generation of scientists she has nurtured, taught and guided. Dr. Prokunina-Olsson’s admiration for diversity and ability to recognize potential, particularly in minority scientists, and then develop a trajectory for their success, have played an important role in establishing the careers of her fellows who then go on to become mentors themselves.

David Artis and Wanjun Chen are jointly recognized for the 2022 ICIS-BioLegend William E. Paul Award for their combined contributions to unraveling the exciting and important biology of cytokines

David Artis and Wanjun Chen are jointly recognized for the 2022 ICIS-BioLegend William E. Paul Award for their combined contributions to unraveling the exciting and important biology of cytokines. David Artis’ work has pushed the boundaries of conventional approaches to immune defenses, and elucidated the important role of cytokines in host defenses at the barrier surfaces of the gut, skin, and lungs. Wanjun Chen’s work has significantly advanced our understanding of pathogenesis and has led to the development of immunotherapies for autoimmunity, cancer, and infectious diseases.

Akihiko Yoshimura has been chosen for the 2022 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020)

The ICIS recognizes Akihiko Yoshimura as the 2022 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research, the society’s most prestigious award, for his outstanding discoveries in the field of cytokine biology that have transformed human medicine. Professor Yoshimura’s ground breaking discoveries have played an important role in inflammation, allergy, autoimmune diseases, and tumor immunity.